Skip to content

Aquatic Exercise for Cognition and Mobility in Older Adults

Effects of Aquatic Integrated Cognitive Motor Training on Cognition and Mobility in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05501249
Enrollment
25
Registered
2022-08-15
Start date
2022-02-01
Completion date
2022-12-12
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging Problems, Aging Well, Cognitive Change, Gait, Unsteady, Mobility Limitation

Keywords

Aquatic exercise, Fall prevention, Functional mobility

Brief summary

The purpose of this study is to assess the effects of an aquatic exercise program on cognition and physical function of older adults.

Interventions

BEHAVIORALAquatic Integrated Cognitive Motor Training

Aquatic exercise class with focus on cognitive and physical exercise

Sponsors

Emily Dunlap
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able to ambulate 100 ft independently with or without assistive device * Score greater than or equal to 3 on the Mini-Cog Test * Stable medical condition within one month prior to the study * Stable exercise program within one month prior to the study * Available during study testing and group class times * COVID-19 vaccination * Permission from medical provider to participate in the study

Exclusion criteria

* History of dementia or Alzheimer's * Contraindication to exercise or pool immersion (e.g., unstable cardiovascular conditions, fever, diarrhea, aqua-phobia)

Design outcomes

Primary

MeasureTime frameDescription
Stroop Effect Test: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksMeasure of working memory and attention
Trail Making Test A and B: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksMeasure of visual scanning and working memory
Digit Backwards Test : Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksMeasure of working memory capacity
Gait Measurements: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeks4 gait conditions (single task gait, dual task gait with head turns, dual task gait with head nods, and dual task gait count backwards by serial 7s). Gait measures collected with Strideway Gait Analysis System.
Functional Outcome Measures: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksTimed Up and Go Test, Cognitive Timed Up and Go Test, Single Leg Balance Test, and Four Square Step Test.

Secondary

MeasureTime frameDescription
Vital Sign measurements: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksBlood pressure and heart rate taken after 5 min supine, immediately upon standing, and 2 min after standing
Activities-specific balance confidence scale: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksA structured questionnaire that measures an individuals confidence performing daily activities. The minimum score is 0% (no confidence in balance) to 100% (complete confidence in balance).
Anthropometric measurements: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksHeight and weight
Neurotrophic Growth Factors: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksSerum concentration of brain derived neurotrophic factor and insulin-like growth factor 1
Numeric Pain Rating Scale: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksAn 11 point scale for level of pain from 0 (no pain) to 10 (severe pain).
Global Rating of Change Questionnaire: Change from baseline to the end of intervention/control periodMeasures taken at baseline and again at approximately 9-10 weeksA 15 point global rating scale for changes in domains, from -7 (a great deal worse); through 0 (no change) to +7 (a great deal better).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026